These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11244315)

  • 1. Apoptosis of renal tubular cells in Shiga-toxin-mediated hemolytic uremic syndrome.
    Kaneko K; Kiyokawa N; Ohtomo Y; Nagaoka R; Yamashiro Y; Taguchi T; Mori T; Fujimoto J; Takeda T
    Nephron; 2001 Feb; 87(2):182-5. PubMed ID: 11244315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of polyunsaturated fatty acids to Shiga toxin cytotoxicity in human renal tubular epithelium-derived cells.
    Sasaki TK; Takita T
    Biochem Cell Biol; 2006 Apr; 84(2):157-66. PubMed ID: 16609696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome.
    Ray PE; Liu XH
    Pediatr Nephrol; 2001 Oct; 16(10):823-39. PubMed ID: 11605791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shiga toxin-2 results in renal tubular injury but not thrombotic microangiopathy in heterozygous factor H-deficient mice.
    Paixão-Cavalcante D; Botto M; Cook HT; Pickering MC
    Clin Exp Immunol; 2009 Feb; 155(2):339-47. PubMed ID: 19040606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The detection of Shiga toxins in the kidney of a patient with hemolytic uremic syndrome.
    Uchida H; Kiyokawa N; Horie H; Fujimoto J; Takeda T
    Pediatr Res; 1999 Jan; 45(1):133-7. PubMed ID: 9890621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shiga toxin-associated hemolytic uremic syndrome: absence of recurrence after renal transplantation.
    Ferraris JR; Ramirez JA; Ruiz S; Caletti MG; Vallejo G; Piantanida JJ; Araujo JL; Sojo ET
    Pediatr Nephrol; 2002 Oct; 17(10):809-14. PubMed ID: 12376808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies.
    Karpman D; Håkansson A; Perez MT; Isaksson C; Carlemalm E; Caprioli A; Svanborg C
    Infect Immun; 1998 Feb; 66(2):636-44. PubMed ID: 9453620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shiga toxin targets the podocyte causing hemolytic uremic syndrome through endothelial complement activation.
    Bowen EE; Hurcombe JA; Barrington F; Keir LS; Farmer LK; Wherlock MD; Ortiz-Sandoval CG; Bruno V; Bohorquez-Hernandez A; Diatlov D; Rostam-Shirazi N; Wells S; Stewart M; Teboul L; Lay AC; Butler MJ; Pope RJP; Larkai EMS; Morgan BP; Moppett J; Satchell SC; Welsh GI; Walker PD; Licht C; Saleem MA; Coward RJM
    Med; 2023 Nov; 4(11):761-777.e8. PubMed ID: 37863058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shiga Toxin Mediated Neurologic Changes in Murine Model of Disease.
    Pradhan S; Pellino C; MacMaster K; Coyle D; Weiss AA
    Front Cell Infect Microbiol; 2016; 6():114. PubMed ID: 27747196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemolytic uremic syndrome induced by lipopolysaccharide and Shiga-like toxin.
    Ikeda M; Ito S; Honda M
    Pediatr Nephrol; 2004 May; 19(5):485-9. PubMed ID: 15007712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escherichia coli Shiga toxin.
    Nakao H; Takeda T
    J Nat Toxins; 2000 Aug; 9(3):299-313. PubMed ID: 10994531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of shiga toxin 2 on cellular regeneration mechanisms in primary and three-dimensional cultures of human renal tubular epithelial cells.
    Márquez LB; Araoz A; Repetto HA; Ibarra FR; Silberstein C
    Microb Pathog; 2016 Oct; 99():87-94. PubMed ID: 27521227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis and pathological characteristics of five children with non-Shiga toxin-mediated hemolytic uremic syndrome.
    Kamioka I; Nozu K; Fujita T; Kaito H; Tanaka R; Yoshiya K; Iijima K; Nakanishi K; Yoshikawa N; Matsuo M
    Pediatr Int; 2007 Apr; 49(2):196-201. PubMed ID: 17445038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine expression in the renal tubular epithelial cells stimulated by Shiga toxin 2 of Escherichia coli O157:H7.
    Lee JE; Kim JS; Choi IH; Tagawa M; Kohsaka T; Jin DK
    Ren Fail; 2002 Sep; 24(5):567-75. PubMed ID: 12380901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic use of a receptor mimic probiotic reduces intestinal Shiga toxin levels in a piglet model of hemolytic uremic syndrome.
    Hostetter SJ; Helgerson AF; Paton JC; Paton AW; Cornick NA
    BMC Res Notes; 2014 Jun; 7():331. PubMed ID: 24890228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. von Willebrand Factor expression in a Shiga toxin-mediated primate model of hemolytic uremic syndrome.
    Pysher TJ; Siegler RL; Tesh VL; Taylor FB
    Pediatr Dev Pathol; 2002; 5(5):472-9. PubMed ID: 12196894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of shiga toxin concentrations in the blood of patients with hemolytic uremic syndrome.
    Brigotti M; Tazzari PL; Ravanelli E; Carnicelli D; Rocchi L; Arfilli V; Scavia G; Minelli F; Ricci F; Pagliaro P; Ferretti AV; Pecoraro C; Paglialonga F; Edefonti A; Procaccino MA; Tozzi AE; Caprioli A
    Pediatr Infect Dis J; 2011 Jun; 30(6):486-90. PubMed ID: 21164386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Human Derived Blood Outgrowth Endothelial Cells: An Appropriate In Vitro Model to Study Shiga Toxin Mediated Damage of Endothelial Cells.
    Feitz WJC; van de Kar NCAJ; Cheong I; van der Velden TJAM; Ortiz-Sandoval CG; Orth-Höller D; van den Heuvel LPJW; Licht C
    Toxins (Basel); 2020 Jul; 12(8):. PubMed ID: 32751286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.
    Morigi M; Galbusera M; Gastoldi S; Locatelli M; Buelli S; Pezzotta A; Pagani C; Noris M; Gobbi M; Stravalaci M; Rottoli D; Tedesco F; Remuzzi G; Zoja C
    J Immunol; 2011 Jul; 187(1):172-80. PubMed ID: 21642543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytotoxic effect of Shiga toxin type 2 and its B subunit on human renal tubular epithelial cell cultures].
    Creydt VP; Nuñez P; Zotta E; Ibarra C
    Medicina (B Aires); 2005; 65(2):147-50. PubMed ID: 16075810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.